 FLORHAM PARK, N.J., Jan. 13, 2023 GLOBE NEWSWIRE PDS Biotechnology Corporation Nasdaq: PDSB, a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that its management will participate in a fireside chat at the B. Riley Securities 3rd Annual Oncology Conference being held virtually on January ... The post PDS Biotech to Participate at the B. Riley Securities 3rd Annual Oncology Conference appeared... 